How many insider trades does FilingIQ track for PRLD?

FilingIQ tracks 189 Form 4 insider transactions for PRLD (Prelude Therapeutics Inc), covering filings from Sep 25, 2020 onwards. 9 of those were filed in the last 90 days.

Are PRLD insiders net buyers or net sellers?

Across the full Form 4 history for PRLD, 43 transactions (23%) were open-market purchases and 67 (35%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does PRLD insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is PRLD in?

Prelude Therapeutics Inc (PRLD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $295.47M.

PRLD insider trading

NasdaqGS Healthcare

Prelude Therapeutics Inc — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

189

Last 90 days

Buys / sells

23% / 35%

Market cap

$295.47M

About Prelude Therapeutics Inc

Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing JAK2V617F, a driver mutation product for the treatment of myeloproliferative neoplasms, myelofibrosis (MF), polycythemia vera, and essential thrombocythemia (ET); KAT6A for the treatment of advanced breast cancer and other solid tumors; and mutated calreticulin degrader antibody conjugates to treat MF and ET. The company has collaboration with AbCellera Biologics to discover, develop, and commercialize novel degrader antibody conjugates. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.

Company website: preludetx.com

PRLD insider activity at a glance

FilingIQ has scored 189 insider transactions for PRLD since Sep 25, 2020. The most recent filing in our index is dated May 1, 2026.

Across the full history, 43 open-market purchases and 67 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PRLD insider trades is 56.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live PRLD trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for PRLD?: FilingIQ tracks 189 Form 4 insider transactions for PRLD (Prelude Therapeutics Inc), covering filings from Sep 25, 2020 onwards. 9 of those were filed in the last 90 days.
Are PRLD insiders net buyers or net sellers?: Across the full Form 4 history for PRLD, 43 transactions (23%) were open-market purchases and 67 (35%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PRLD insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is PRLD in?: Prelude Therapeutics Inc (PRLD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $295.47M.

Methodology & sources

Every PRLD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.